348 related articles for article (PubMed ID: 29764444)
41. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of ion channel genes in Chinese patients with gliomas based on mRNA expression profiling.
Lu FF; Wang HY; He XZ; Liang TY; Wang W; Hu HM; Wu F; Liu YW; Zhang SZ
J Neurooncol; 2017 Sep; 134(2):397-405. PubMed ID: 28752501
[TBL] [Abstract][Full Text] [Related]
43. Small-molecule PTPN2 Inhibitors Sensitize Resistant Melanoma to Anti-PD-1 Immunotherapy.
Zhu Z; Tang R; Huff S; Kummetha IR; Wang L; Li N; Rana TM
Cancer Res Commun; 2023 Jan; 3(1):119-129. PubMed ID: 36968224
[TBL] [Abstract][Full Text] [Related]
44. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
Front Immunol; 2021; 12():628966. PubMed ID: 33664747
[TBL] [Abstract][Full Text] [Related]
45. PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.
Song J; Lan J; Tang J; Luo N
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077422
[TBL] [Abstract][Full Text] [Related]
46. Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.
Wang J; Xu S; Lv W; Shi F; Mei S; Shan A; Xu J; Yang Y
Cancer Med; 2020 Aug; 9(16):5940-5947. PubMed ID: 32583596
[TBL] [Abstract][Full Text] [Related]
47. IFI30 expression is an independent unfavourable prognostic factor in glioma.
Liu X; Song C; Yang S; Ji Q; Chen F; Li W
J Cell Mol Med; 2020 Nov; 24(21):12433-12443. PubMed ID: 32969157
[TBL] [Abstract][Full Text] [Related]
48. Interferon regulatory factor transcript levels correlate with clinical outcomes in human glioma.
Lei J; Zhou MH; Zhang FC; Wu K; Liu SW; Niu HQ
Aging (Albany NY); 2021 Apr; 13(8):12086-12098. PubMed ID: 33902005
[TBL] [Abstract][Full Text] [Related]
49. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.
Kiviniemi A; Gardberg M; Kivinen K; Posti JP; Vuorinen V; Sipilä J; Rahi M; Sankinen M; Minn H
Oncotarget; 2017 Jul; 8(30):49123-49132. PubMed ID: 28467778
[TBL] [Abstract][Full Text] [Related]
50. The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis.
Ghouzlani A; Lakhdar A; Rafii S; Karkouri M; Badou A
Sci Rep; 2021 Nov; 11(1):21504. PubMed ID: 34728682
[TBL] [Abstract][Full Text] [Related]
51.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
52. Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas.
Yang P; Wang K; Zhang C; Wang Z; Liu Q; Wang J; Jiang T; Shan X
Cancer Immunol Immunother; 2021 Sep; 70(9):2589-2600. PubMed ID: 33576871
[TBL] [Abstract][Full Text] [Related]
53. CD70, a novel target of CAR T-cell therapy for gliomas.
Jin L; Ge H; Long Y; Yang C; Chang YE; Mu L; Sayour EJ; De Leon G; Wang QJ; Yang JC; Kubilis PS; Bao H; Xia S; Lu D; Kong Y; Hu L; Shang Y; Jiang C; Nie J; Li S; Gu Y; Sun J; Mitchell DA; Lin Z; Huang J
Neuro Oncol; 2018 Jan; 20(1):55-65. PubMed ID: 28651374
[TBL] [Abstract][Full Text] [Related]
54. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
55. Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel disease.
Spalinger MR; McCole DF; Rogler G; Scharl M
World J Gastroenterol; 2016 Jan; 22(3):1034-44. PubMed ID: 26811645
[TBL] [Abstract][Full Text] [Related]
56. Tumor Purity as an Underlying Key Factor in Glioma.
Zhang C; Cheng W; Ren X; Wang Z; Liu X; Li G; Han S; Jiang T; Wu A
Clin Cancer Res; 2017 Oct; 23(20):6279-6291. PubMed ID: 28754819
[No Abstract] [Full Text] [Related]
57. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2.
Scharl M; Paul G; Weber A; Jung BC; Docherty MJ; Hausmann M; Rogler G; Barrett KE; McCole DF
Gastroenterology; 2009 Dec; 137(6):2030-2040.e5. PubMed ID: 19818778
[TBL] [Abstract][Full Text] [Related]
58. 25-Hydroxyvitamin D
Zhang P; Zhang W; Zhang D; Wang M; Aprecio R; Ji N; Mohamed O; Li Y; Ding Y; Wang Q
J Periodontal Res; 2018 Jun; 53(3):467-477. PubMed ID: 29516520
[TBL] [Abstract][Full Text] [Related]
59. Increased Tau Expression Correlates With IDH Mutation in Infiltrating Gliomas and Impairs Cell Migration.
Nakata S; Price A; Eberhart C; Morris M
J Neuropathol Exp Neurol; 2020 May; 79(5):493-499. PubMed ID: 32181806
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma.
Bourgonje AM; Verrijp K; Schepens JT; Navis AC; Piepers JA; Palmen CB; van den Eijnden M; Hooft van Huijsduijnen R; Wesseling P; Leenders WP; Hendriks WJ
Acta Neuropathol Commun; 2016 Sep; 4(1):96. PubMed ID: 27586084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
